Nancy Schimelpfening is an Editor at Wealth Creation Investing. She specializes in health and wellness, focusing on topics such as aging and longevity, diet and nutrition, fitness, and mental health care. Nancy's work has been featured in notable publications including AOL, Inc., Healthgrades, Healthline Media, Inc., and New Health Digest.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Nancy Schimelpfening's coverage focuses heavily on health and scientific topics, particularly around diabetes, weight loss, medications, aging, mental health, and heart health. She often cites data in her articles.
When reaching out to Nancy with pitches or expert commentary opportunities, consider offering the latest research findings or insights backed by credible data within the healthcare and pharmaceutical sectors. Topics related to innovative treatments for chronic conditions such as diabetes and osteoarthritis might be of particular interest to her audience.
Given her focus on providing evidence-based information regarding various health issues including but not limited to weight management and mental well-being; outreach should include experts who can provide substantial data-driven insights into these areas.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Nancy Schimelpfening
GLP-1 drugs can provide benefits that may boost an athlete’s performance, but do these medications give them the competitive edge?
Debates are emerging over whether GLP-1 drugs boost athletic performance However, experts say the loss of lean mass associated with using these drugs may cancel out any competitive advantages.
By: Nancy Schimelpfening
A large review suggests that creatine could be an adjunct treatment for major depressive disorder (MDD).
A large review suggests that creatine could help alleviate symptoms of major depressive disorder (MDD). While the evidence is mixed, creatine has an excellent safety profile and could work as an add-on therapy to current depression treatments.
By: Nancy Schimelpfening
A new study suggests not getting enough sleep each night may lead to weight gain. Those who lost an average of 78 minutes of sleep per night gained almost 1 pound over 6 weeks.
By: Ms, Nancy Schimelpfening
A new study found that while several newer obesity medications can help with significant weight loss, they often do not improve quality of life or boost long-term heart health. Here's why.
By: Nancy Schimelpfening
A new study found that while several newer obesity medications can help with significant weight loss, they often do not improve quality of life or boost long-term heart health. Here's why.
A new study found that adults who slept about 78 fewer minutes each night for six weeks gained nearly a pound and became more sedentary, highlighting the important role sleep plays in maintaining a healthy weight.
By: Nancy Schimelpfening, Ms
Experts say addressing these 14 modifiable risk factors may help lower your risk of dementia. Here's how.
By: Nancy Schimelpfening
Nancy Schimelpfening, MS Millions of people around the world are living with cognitive impairment associated with dementia.
